Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants

British Journal of Haematology

Volumn 145, Issue 1, 2009, Pages 107-114

  Michonneau, David ^a   Peffault De Latour, Régis ^a   Porcher, Raphaël ^b   Robin, Marie ^a   Benbunan, Marc ^c   Rocha, Vanderson ^a   Ribaud, Patricia ^a   Ferry, Christele ^a   Devergie, Agnes ^a   Vanneaux, Valérie ^c   Gluckman, Eliane ^a   Marolleau, Jean Pierre ^d   Socié, Gérard ^a   Larghero, Jérôme ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

B lymphocytes; Bone marrow transplantation; Graft versus host disease

Indexed keywords

ANTIGEN; CYCLOSPORIN A; METHOTREXATE; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CD34+ CD19+ B LYMPHOCYTE; DONOR; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTIGENS, CD34; B-LYMPHOCYTES; BONE MARROW DISEASES; BONE MARROW TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK; SIBLINGS; STEM CELLS; SURVIVAL RATE; TRANSPLANTATION, ISOGENEIC;

EID: 61849178767     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07574.x     Document Type: Article

References (31)

1. Barrett, A.J., Ringdén, O., Zhang, M.J., Bashey, A., Cahn, J.Y., Cairo, M.S., Gale, R.P., Gratwohl, A., Locatelli, F., Martino, R., Schultz, K.R. Tiberghien, P. (2000) Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood, 95, 3323 3327.
2. Bennett, S.R., Carbone, F.R., Toy, T., Miller, J.F. Heath, W.R. (1998) B cells directly tolerize CD8(+) T cells. Journal of Experimental Medicine, 188, 1977 1983.
3. Bittencourt, H., Rocha, V., Chevret, S., Socié, G., Espérou, H., Devergie, A., Dal Cortivo, L., Marolleau, J.P., Garnier, F., Ribaud, P. Gluckman, E. (2002) Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood, 99, 2726 2733.
4. Blom, B. Spits, H. (2006) Development of human lymphoid cells. Annual Review of Immunology, 24, 287 320.
5. Eynon, E.E. Parker, D.C. (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. Journal of Experimental Medicine, 175, 131 138.
6. Eynon, E.E. Parker, D.C. (1993) Parameters of tolerance induction by antigen targeted to B lymphocytes. Journal of Immunology, 151, 2958 2964.
7. Fehr, T., Wang, S., Haspot, F., Kurtz, J., Blaha, P., Hogan, T., Chittenden, M., Wekerle, T. Sykes, M. (2008) Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells. Journal of Immunology, 181, 4371 4380.
8. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D. Anderton, S.M. (2002) B cells regulate autoimmunity by provision of IL-10. Nature Immunology, 3, 944 950.
9. Fillatreau, S., Gray, D. Anderton, S.M. (2008) Not always the bad guys: B cells as regulators of autoimmune pathology. Nature Reviews, 8, 391 397.
10. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295 304.
11. Hou, Y.H., Srour, E.F., Ramsey, H., Dahl, R., Broxmeyer, H.E. Hromas, R. (2005) Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood, 105, 3488 3492.
12. Iori, A.P., Torelli, G.F., De Propris, M.S., Milano, F., Pupella, S., Gozzer, M., Mancini, F., Milani, M.L., Intoppa, S., Cerretti, R., Lucarelli, B., Valle, V., Malandruccolo, L., Iannella, E., Arleo, E., Guarini, A. Foà, R. (2008) B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation. Transplantation, 85, 386 390.
13. Kim, D.H., Sohn, S.K., Lee, N.Y., Baek, J.H., Kim, J.G., Won, D.I., Suh, J.S., Lee, K.B. Shin, I.H. (2005) Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. European Journal of Haematology, 75, 299 308.
14. Larghero, J., Rocha, V., Porcher, R., Filion, A., Ternaux, B., Lacassagne, M.N., Robin, M., Peffault de Latour, R., Devergie, A., Biscay, N., Ribaud, P., Benbunan, M., Gluckman, E., Marolleau, J.P. Socié, G. (2007) Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants. British Journal of Haematology, 138, 101 109.
15. Lee, S.J., Vogelsang, G. Flowers, M.E. (2003) Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 9, 215 233.
16. Lin, M.T., Storer, B., Martin, P.J., Tseng, L.H., Gooley, T., Chen, P.J. Hansen, J.A. (2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. New England Journal of Medicine, 349, 2201 2210.
17. Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C. Barrett, J. (1996) CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3223 3229.
18. Mizoguchi, A. Bhan, A.K. (2006) A case for regulatory B cells. Journal of Immunology, 176, 705 710.
19. Morariu-Zamfir, R., Rocha, V., Devergie, A., Socié, G., Ribaud, P., Esperou, H., Parquet, N., Guardiola, P., Dal Cortivo, L., Bittencourt, H., Garnier, F., Traineau, R., Marolleau, J.P., Chevret, S. Gluckman, E. (2001) Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplantation, 27, 575 580.
20. Niimi, M., Hara, M., Witzke, O., Morris, P.J. Wood, K.J. (1998) Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. Transplantation, 66, 1786 1792.
21. Ratanatharathorn, V., Ayash, L., Reynolds, C., Silver, S., Reddy, P., Becker, M., Ferrara, J.L. Uberti, J.P. (2003) Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biology of Blood and Marrow Transplantation, 9, 505 511.
22. Reynaud, D., Lefort, N., Manie, E., Coulombel, L. Levy, Y. (2003) In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. Blood, 101, 4313 4321.
23. Rocha, V., Carmagnat, M.V., Chevret, S., Flinois, O., Bittencourt, H., Esperou, H., Garnier, F., Ribaud, P., Devergie, A., Socié, G., Dal'Cortivo, L., Marolleau, J.P., Charron, D., Gluckman, E. Rabian, C. (2001) Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants. Experimental Hematology, 29, 1347 1352.
24. Rowe, V., Banovic, T., MacDonald, K.P., Kuns, R., Don, A.L., Morris, E.S., Burman, A.C., Bofinger, H.M., Clouston, A.D. Hill, G.R. (2006) Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood, 108, 2485 2492.
25. Schultz, K.R., Paquet, J., Bader, S. HayGlass, K.T. (1995) Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplantation, 16, 289 295.
26. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204 217.
27. Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M. Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 4226 4235.
28. Singhal, S., Powles, R., Treleaven, J., Kulkarni, S., Sirohi, B., Horton, C., Millar, B., Shepherd, V., Tait, D., Saso, R., Rowland, A., Long, S. Mehta, J. (2000) A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplantation, 26, 489 496.
29. Storek, J., Wells, D., Dawson, M.A., Storer, B. Maloney, D.G. (2001) Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood, 98, 489 491.
30. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K. Thomas, E.D. (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood, 57, 267 276.
31. Yamasaki, S., Henzan, H., Ohno, Y., Yamanaka, T., Iino, T., Itou, Y., Kuroiwa, M., Maeda, M., Kawano, N., Kinukawa, N., Miyamoto, T., Nagafuji, K., Shimoda, K., Inaba, S., Hayashi, S., Taniguchi, S., Shibuya, T., Gondo, H., Otsuka, T., Harada, M., Fukuoka Blood Marrow Transplantation.Group. (2003) Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors. Bone Marrow Transplantation, 32, 505 510.